Table 1.
Breast Cancer (n=13 Female) |
Healthy Control (n=13 Female) |
|
---|---|---|
Mean (SD) or N(%) | Mean (SD) or N(%) | |
Age at baseline (years) | 47.85 (6.4) | 48.54 (8.0) |
Education (years) | 17.23 (2.35) | 16.08 (1.71) |
Handedness | ||
Right | 13 (100) | 13 (100) |
Left | 0 (0) | 0 (0) |
Time between scans (days) | 152.69 (22.9) | 163.58 (17.98) |
Race | ||
White | 4 (30.8) | 11 (84.6) |
Black or African-American | 2 (15.4) | 2 (16.7) |
Asian | 5 (38.5) | 0 (0) |
Hispanic or Latino | 2 (15.4) | 0 (0) |
Native Hawaiian or Other Pacific Islander | 0 (0) | 0 (0) |
American Indian or Alaska Native | 0 (0) | 0 (0) |
Cancer stage | ||
I | 3 (23.1) | |
II | 6 (46.2) | |
III | 2 (15.4) | |
IV | 0 (0) | |
No Stage recorded | 2 (15.4) | |
Chemotherapy | ||
Adriamycin, Cytoxan, and Taxol | 9 (69.2) | |
Cyclophosphamide, methotrexate, and fluorouracil | 4 (30.8) |
Groups did not significantly differ across demographic characteristics of age (t(24) = 0.243, p = 0.81); education (t(24) = −1.432, p = 0.165); time between scans (t(24) = 0.681, p = 0.502)